Literature DB >> 1751774

Tumor necrosis factor-alpha, interleukin 1, and phorbol myristate acetate are independent activators of NF-kappa B which differentially activate T cells.

S W Krasnow1, L Q Zhang, K Y Leung, L Osborn, S Kunkel, G J Nabel.   

Abstract

Gene expression in eukaryotic cells can be altered in different ways by extracellular agents, including mitogens and cytokines. Such differential gene expression is mediated in part through the effects of these stimuli on distinct sets of cellular transcription factors. In this report, the effects of phorbol myristate acetate, tumor necrosis factor-alpha (TNF-alpha), and interleukin 1 (IL-1) on differential gene expression in the LBRM mouse T-lymphoma cell line are examined. Although these three different stimuli produce similar levels of induction of the NF-kappa B transcription factor, it is reported that they cause differential expression of other cellular activation genes, including c-fos and IL-2. The roles of IL-1 and TNF-alpha were also analyzed in EL-4 cells in the presence of a second activator, ionomycin. IL-1, but not TNF-alpha, was found to stimulate the IL-2 enhancer in the presence of this costimulator. These findings suggest that one transcription factor can be the target of cellular activators that exert otherwise different effects on gene expression. Cellular activation pathways can therefore be defined by the set of transcription factors stimulated within a cell. This approach may allow a more precise definition of the requirements for differential gene activation in different cell types and thereby provide a basis for the selective manipulation of gene expression in cytokine-responsive cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751774     DOI: 10.1016/1043-4666(91)90040-k

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

Review 1.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

2.  The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type.

Authors:  L Foghsgaard; M Jäättelä
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate.

Authors:  T Luo; J R Downing; J V Garcia
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA).

Authors:  F Tsuji; Y Miyake; H Aono; Y Kawashima; S Mita
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Transcriptomic analysis in the leech Theromyzon tessulatum: involvement of cystatin B in innate immunity.

Authors:  Christophe Lefebvre; Claude Cocquerelle; Franck Vandenbulcke; David Hot; Ludovic Huot; Yves Lemoine; Michel Salzet
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

6.  Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-kappa B in vivo.

Authors:  S L Eck; N D Perkins; D P Carr; G J Nabel
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

7.  Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.

Authors:  M C Hannibal; D M Markovitz; N Clark; G J Nabel
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.

Authors:  G Poli; A L Kinter; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation.

Authors:  J C Bandres; L Ratner
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.

Authors:  Marco Sgarbanti; Anna L Remoli; Giulia Marsili; Barbara Ridolfi; Alessandra Borsetti; Edvige Perrotti; Roberto Orsatti; Ramona Ilari; Leonardo Sernicola; Emilia Stellacci; Barbara Ensoli; Angela Battistini
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.